MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
DBVT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

DBV Technologies S.A (DBVT) Ownership - Who owns DBV Technologies S.A?

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
107 Avenue de la Republique
Phone
+33 155427878
Employees
126
Web
https://www.dbv-technologies.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
960.28M
P/E Ratio
N/A
Total Cash
229.2M
Projected Growth
N/A
Total Debt
6.1M
Revenue
N/A
Risk (Beta)
-1.07
Dividend Yield
N/A
Total Cash/Share
3.87
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
DBVT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for DBVT
A.I. Advisor
published General Information

General Information

a developer of non invasive epicutaneous diagnostics systems and immunotherapy for allergy diagnostics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
107 Avenue de la Republique
Phone
+33 155427878
Employees
126
Web
https://www.dbv-technologies.com